Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Ann Rheum Dis
; 81(11): 1491-1503, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-35922124
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Antirheumatic Agents
/
Lung Diseases
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Ann Rheum Dis
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: